Guardian Partners’s Viemed Healthcare VMD Stock Holding History

Guardian Partners’s Portfolio VMD Stock Details VMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$34K	Buy	+2,980	New	+$29.5K	﹤0.01%	294

Other funds holding VMD

Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return

SummerHaven Investment Management Stamford, Connecticut $187M AUM 70.61% 1-Year Est. Return

North Star Investment Management Chicago, Illinois $1.84B AUM 28.81% 1-Year Est. Return

Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return

Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return

Ulland Investment Advisors Minneapolis, Minnesota $136M AUM 32.68% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Violich Capital Management San Francisco, California $919M AUM 40.7% 1-Year Est. Return

BCM Advisors Lafayette, Louisiana $514M AUM 20.96% 1-Year Est. Return

Cardinal Point Capital Management Toronto, Ontario, Canada $1.77B AUM 26.72% 1-Year Est. Return

Guardian Partners's VMD Position: Q2 2026 in Review

Guardian Partners opened a new position in Viemed Healthcare (VMD) in Q2 2026: 2,980 shares worth $34K. The stake represents ﹤0.01% of the portfolio and ranks #294 among its holdings.

34 funds tracked by Wall St. Rank hold VMD as of Q2 2026.

Guardian Partners held 2,980 shares of Viemed Healthcare worth $34K as of Q2 2026.
Viemed Healthcare was a new Guardian Partners position in Q2 2026.
Viemed Healthcare made up ﹤0.01% of Guardian Partners's portfolio in Q2 2026, its #294 holding.
34 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2026.

Based on Guardian Partners's 13F filing for Q2 2026, filed 29 Jul 2026.